POINT: In the Era of Cystic Fibrosis Transmembrane Regulator Protein Modulator Therapy, Are the Treatment Goals for Adults Now Different From Those for Children With Cystic Fibrosis? Yes

Damian G. Downey*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)18-20
Number of pages3
JournalChest
Volume161
Issue number1
DOIs
Publication statusPublished - 06 Jan 2022

Bibliographical note

Funding Information:
FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: D. G. D. has received honoraria and acted as a clinical trial principal investigator for Vertex Pharmaceuticals and Proteostasis Therapeutics.

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this